TELA Bio Corp (TELA) - נכסים מצרפיים של הפעילות העסקית
TELA Bio, Inc. (TELA) generates revenue by creating advanced biotransplants, with the sale of OviTex reinforced tissues for plastic surgery and hernia repair serving as the primary profit generator. This price chart, which records total assets at 63.64, complements data regarding logistics and the outsourcing of component manufacturing to third-party contractors. The company is currently betting on internal headcount growth and direct clinic access without pursuing mergers.
%20%D7%A1%D7%9A%20%D7%A0%D7%9B%D7%A1%D7%99%20%D7%94%D7%97%D7%91%D7%A8%D7%94&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_TELA_-_TELA-Bio-Inc._-_Company-Total-Assets "telabio.com (TELA) - שווי מצרפי של נכסים מ-04.07.2022 עד 29.10.2026 | 👁️GURU.Markets👁️")
פילוחי מדדים פיננסיים ומדדי שוק עבור telabio.com (TELA)
Scaling the TELA Bio, Inc. (TELA) sales force amidst a chronic cash deficit directly impacts the structure of the balance sheet base. A reverse calculation via ROA allows for the determination of the total cost of resources and liabilities, while the total assets chart captures capital management efficiency under conditions of operating losses and the risks of overpaying for the company as the return on assets declines.